190 related articles for article (PubMed ID: 33316275)
1. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776
[TBL] [Abstract][Full Text] [Related]
3. Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Kazemi M; Hadi A; Pierson RA; Lujan ME; Zello GA; Chilibeck PD
Adv Nutr; 2021 Feb; 12(1):161-178. PubMed ID: 32805007
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
Koval KW; Setji TL; Reyes E; Brown AJ
J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
[TBL] [Abstract][Full Text] [Related]
10. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
Marchesan LB; Spritzer PM
Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women.
Kazemi M; Kim JY; Wan C; Xiong JD; Michalak J; Xavier IB; Ganga K; Tay CT; Grieger JA; Parry SA; Moran LJ; Lujan ME
Hum Reprod Update; 2022 Nov; 28(6):910-955. PubMed ID: 35639552
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study.
Chen W; Srinivasan SR; Elkasabany A; Berenson GS
Am J Epidemiol; 1999 Oct; 150(7):667-74. PubMed ID: 10512420
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
Legro RS; Kunselman AR; Dunaif A
Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
Marlatt KL; Redman LM; Beyl RA; Smith SR; Champagne CM; Yi F; Lovejoy JC
Am J Obstet Gynecol; 2020 Apr; 222(4):365.e1-365.e18. PubMed ID: 31610152
[TBL] [Abstract][Full Text] [Related]
16. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.
Glueck CJ; Morrison JA; Goldenberg N; Wang P
Metabolism; 2009 May; 58(5):714-21. PubMed ID: 19375597
[TBL] [Abstract][Full Text] [Related]
17. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome.
Arya S; Hansen KR; Peck JD; Wild RA;
Am J Obstet Gynecol; 2021 Sep; 225(3):280.e1-280.e11. PubMed ID: 33852887
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
20. The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.
Halperin IJ; Kumar SS; Stroup DF; Laredo SE
Hum Reprod; 2011 Jan; 26(1):191-201. PubMed ID: 21059754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]